Neuroprotective Role of Trans-Resveratrol in a Murine Model of Familial Alzheimer's Disease

Porquet, David; Grinan-Ferre, Christian; Ferrer, Isidre; Camins, Antoni; Sanfeliu, Coral; del Valle, Jaume; Pallas, Merce


The amyloid-beta protein precursor/presenilin 1 (A beta PP/PS1) mouse model of Alzheimer's disease (AD) has provided robust neuropathological hallmarks of familial AD-like pattern. AD is a neurodegenerative process that causes severe cognitive impairment; it is characterized by the accumulation of amyloid-beta (A beta) and hyperphosphorylated tau forms and by oxidative and inflammatory processes in brain. Currently, efforts are made to understand biochemical pathways because there is no effective therapy for AD. Resveratrol is a polyphenol that induces expression and activation of several neuroprotective pathways involving Sirtuin1 and AMPK. The objective of this work was to assess the effect of oral resveratrol administration on A beta PP/PS1 mice. Long-term resveratrol treatment significantly prevented memory loss as measured by the object recognition test. Moreover, resveratrol reduced the amyloid burden and increased mitochondrial complex IV protein levels in mouse brain. These protective effects of resveratrol were mainly mediated by increased activation of Sirtuin 1 and AMPK pathways in mice. However, an increase has been observed in IL1 beta and TNF gene expression, indicating that resveratrol promoted changes in inflammatory processes, although no changes were detected in other key actors of the oxidative stress pathway. Taken together, our findings suggest that resveratrol is able to reduce the harmful process that occurs in A beta PP/PS1 mouse hippocampus, preventing memory loss.

Más información

Título según WOS: ID WOS:000343763000010 Not found in local WOS DB
Volumen: 42
Número: 4
Editorial: IOS Press
Fecha de publicación: 2014
Página de inicio: 1209
Página final: 1220


Notas: ISI